Skip to content

Research on Electroencephalographic Features Applicable to Sacral Nerve Magnetic Stimulation and Biofeedback for Bowel and Bladder Control

Research on Electroencephalographic Features Applicable to Sacral Nerve Magnetic Stimulation and Biofeedback for Bowel and Bladder Control

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102761
Enrollment
Unknown
Registered
2025-05-20
Start date
2025-05-20
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury

Interventions

Healthy control group:EEG assessment of "sufficiency" and "defecation" movements
Stroke group:EEG assessment of "sufficiency" and "defecation" movements
Spinal Cord Injury Group:EEG assessment of "sufficiency" and "defecation" movements

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age 18-75 years, gender-neutral; 2.Patients with spinal cord injury experiencing impaired or absent voluntary bowel and bladder control. 3.Patients with spinal cord injury above the sacral region are classified by the American Spinal Injury Association (ASIA) into grades A, B, C, and D, regardless of the time since the onset of the injury. 4.No significant cognitive impairment (MMSE illiteracy > 17 points, primary education > 20 points, junior high school and above > 24 points). 5.Signing the Informed Consent Form; Stroke group: 6.In accordance with the diagnostic criteria outlined in the "Key Points for the Diagnosis of Major Cerebrovascular Diseases in China 2019," the following criteria must be met: 1. Acute onset; 2. Focal neurological deficits or global neurological deficits; 3. Confirmation of cerebral infarction or hemorrhage through CT or MRI. 7.The course of stroke onset is greater than or equal to two weeks; 8.No history of central or peripheral nervous system disorders; 9. Age 18-75 years old, gender is not limited; 10. No obvious cognitive dysfunction (MMSE illiteracy> 17 points, 20 points for primary school >, and 24 points > junior high school and above); 11. Informed consent and voluntary participation in this study. Healthy control group: 1) No history of central and peripheral nervous system disease is required; 2) Age greater than 18-75 years old, gender is not limited; 3) No obvious cognitive impairment (MMSE illiteracy> 17 points, 20 points in primary school >, junior high school and above upper >24 points); 4) Those who have informed consent and are willing to participate in this study

Exclusion criteria

Exclusion criteria: 1.Individuals with scalp and skin surface lesions; 2.Individuals with metallic implants in the cranial cavity; 3.Hemispatial neglect or hemianopia; 4.Pregnant and lactating women; 5.Unstable angina, coronary stent implantation within the past six months, and patients with cardiac pacemaker implantation; 6.The researchers believe that individuals with other conditions deemed unsuitable for participation in this clinical trial; 7.Individuals who have participated in or are currently participating in other clinical trials within the three months prior to signing the informed consent form;

Design outcomes

Primary

MeasureTime frame
Event-Related Desynchronization (ERD);Event-Related Synchronization (ERS);

Countries

China

Contacts

Public ContactJie Jia

Huashan Hospital, Fudan University

shannonjj@126.com+86 21 52887820

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026